Flex Pharma Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.88 |
Market Cap |
$9.63 M |
Shares Outstanding |
18.07 M |
Public Float |
14.25 M |
Address |
31 St. James Avenue Boston Massachusetts 02116 United States |
Employees | - |
Website | http://www.flex-pharma.com |
Updated | 07/08/2019 |
Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through the following business segments: Consumer Operations and Drug Development. |